Genocea Provides Third Quarter 2021 Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Genocea Biosciences (GNCA) Tops Q3 EPS by 15c; Reports Cash and Cash Equivalents of $48.9M
October 28, 2021 7:12 AM EDTGenocea Biosciences (NASDAQ: GNCA) reported Q3 EPS of ($0.05), $0.15 better than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.
... More